REFERENCES
1. Berterame S, Erthal J, Thomas J, Fellner S, Vosse B, Clare P, Hao W,
Johnson DT, Mohar A, Pavadia J, Samak AKE, Sipp W, Sumyai V, Suryawati
S, Toufiq J, Yans R, Mattick RP. Use of and barriers to access to opioid
analgesics: a worldwide, regional, and national study. The Lancet 2016;
387: 1644-56.
2. Wilson N. Drug and Opioid-Involved Overdose Deaths—United States,
2017–2018. MMWR Morbidity and mortality weekly report 2020; 69.
3. Centers for Disease Control and Prevention. National Vital Statistics
Reports. Deaths: Final Data for 2017In, 2019.
4. Karanges EA, Blanch B, Buckley NA, Pearson S-A. Twenty-five years of
prescription opioid use in Australia: a whole-of-population analysis
using pharmaceutical claims. Br J Clin Pharmacol 2016; 82: 255-67.
5. Busse JW, Wang L, Kamaleldin M, Craigie S, Riva JJ, Montoya L, Mulla
SM, Lopes LC, Vogel N, Chen E, Kirmayr K, De Oliveira K, Olivieri L,
Kaushal A, Chaparro LE, Oyberman I, Agarwal A, Couban R, Tsoi L, Lam T,
Vandvik PO, Hsu S, Bala MM, Schandelmaier S, Scheidecker A, Ebrahim S,
Ashoorion V, Rehman Y, Hong PJ, Ross S, Johnston BC, Kunz R, Sun X,
Buckley N, Sessler DI, Guyatt GH. Opioids for Chronic Noncancer Pain: A
Systematic Review and Meta-analysis. Jama 2018; 320: 2448-60.
6. Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids
for Chronic Pain–United States, 2016. Jama 2016; 315: 1624-45.
7. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C,
Schoelles KM, Chou R. Long‐term opioid management for chronic noncancer
pain. Cochrane Database of Systematic Reviews 2010.
8. Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, Dana
T, Bougatsos C, Deyo RA. The effectiveness and risks of long-term opioid
therapy for chronic pain: a systematic review for a National Institutes
of Health Pathways to Prevention Workshop. Annals of internal medicine
2015; 162: 276-86.
9. Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ,
Agoritsas T, Akl EA, Carrasco-Labra A, Cooper L, Cull C, da Costa BR,
Frank JW, Grant G, Iorio A, Persaud N, Stern S, Tugwell P, Vandvik PO,
Guyatt GH. Guideline for opioid therapy and chronic noncancer pain. CMAJ
: Canadian Medical Association journal = journal de l’Association
medicale canadienne 2017; 189: E659-e66.
10. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO,
Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, Von Korff
M. Opioid prescriptions for chronic pain and overdose: a cohort study.
Annals of internal medicine 2010; 152: 85-92.
11. Els C, Jackson TD, Kunyk D, Lappi VG, Sonnenberg B, Hagtvedt R,
Sharma S, Kolahdooz F, Straube S. Adverse events associated with medium-
and long-term use of opioids for chronic non-cancer pain: an overview of
Cochrane Reviews. The Cochrane database of systematic reviews 2017; 10:
Cd012509.
12. Manchikanti L, Kaye AM, Knezevic NN, McAnally H, Slavin K, Trescot
AM, Blank S, Pampati V, Abdi S, Grider JS, Kaye AD, Manchikanti KN,
Cordner H, Gharibo CG, Harned ME, Albers SL, Atluri S, Aydin SM, Bakshi
S, Barkin RL, Benyamin RM, Boswell MV, Buenaventura RM, Calodney AK,
Cedeno DL, Datta S, Deer TR, Fellows B, Galan V, Grami V, Hansen H, Helm
Ii S, Justiz R, Koyyalagunta D, Malla Y, Navani A, Nouri KH, Pasupuleti
R, Sehgal N, Silverman SM, Simopoulos TT, Singh V, Solanki DR, Staats
PS, Vallejo R, Wargo BW, Watanabe A, Hirsch JA. Responsible, Safe, and
Effective Prescription of Opioids for Chronic Non-Cancer Pain: American
Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain
physician 2017; 20: S3-s92.
13. Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV,
Brown KR, Bruel BM, Bryce DA, Burks PA, Burton AW, Calodney AK, Caraway
DL, Cash KA, Christo PJ, Damron KS, Datta S, Deer TR, Diwan S, Eriator
I, Falco FJ, Fellows B, Geffert S, Gharibo CG, Glaser SE, Grider JS,
Hameed H, Hameed M, Hansen H, Harned ME, Hayek SM, Helm S, 2nd, Hirsch
JA, Janata JW, Kaye AD, Kaye AM, Kloth DS, Koyyalagunta D, Lee M, Malla
Y, Manchikanti KN, McManus CD, Pampati V, Parr AT, Pasupuleti R, Patel
VB, Sehgal N, Silverman SM, Singh V, Smith HS, Snook LT, Solanki DR,
Tracy DH, Vallejo R, Wargo BW. American Society of Interventional Pain
Physicians (ASIPP) guidelines for responsible opioid prescribing in
chronic non-cancer pain: Part I–evidence assessment. Pain physician
2012; 15: S1-65.
14. Karmali RN, Bush C, Raman SR, Campbell CI, Skinner AC, Roberts AW.
Long-term opioid therapy definitions and predictors: A systematic
review. Pharmacoepidemiology and drug safety 2020; 29: 252-69.
15. Jivraj NK, Raghavji F, Bethell J, Wijeysundera DN, Ladha KS, Bateman
BT, Neuman MD, Wunsch H. Persistent Postoperative Opioid Use: A
Systematic Literature Search of Definitions and Population-based Cohort
Study. Anesthesiology 2020; 132: 1528-39.
16. Nielsen S, Degenhardt L, Hoban B, Gisev N. A synthesis of oral
morphine equivalents (OME) for opioid utilisation studies.
Pharmacoepidemiology and drug safety 2016; 25: 733-37.
17. Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I,
Sorensen HT, von Elm E, Langan SM, Committee RW. The REporting of
studies Conducted using Observational Routinely-collected health Data
(RECORD) statement. PLoS Med 2015; 12: e1001885.
18. Landis JR, Koch GG. The measurement of observer agreement for
categorical data. biometrics 1977: 159-74.
19. Gisev N, Bell JS, Chen TF. Interrater agreement and interrater
reliability: key concepts, approaches, and applications. Research in
social & administrative pharmacy : RSAP 2013; 9: 330-8.
20. Hunnicutt JN, Chrysanthopoulou SA, Ulbricht CM, Hume AL, Tjia J,
Lapane KL. Prevalence of Long-Term Opioid Use in Long-Stay Nursing Home
Residents. Journal of the American Geriatrics Society 2018; 66: 48-55.
21. Solomon DH, Avorn J, Wang PS, Vaillant G, Cabral D, Mogun H, Sturmer
T. Prescription opioid use among older adults with arthritis or low back
pain. Arthritis Rheum 2006; 55: 35-41.
22. Chui PW, Bastian LA, DeRycke E, Brandt CA, Becker WC, Goulet JL.
Dual Use of Department of Veterans Affairs and Medicare Benefits on
High-Risk Opioid Prescriptions in Veterans Aged 65 Years and Older:
Insights from the VA Musculoskeletal Disorders Cohort. Health Services
Research 2018; 53: 5402-18.
23. Daoust R, Paquet J, Moore L, Gosselin S, Gelinas C, Rouleau DM,
Berube M, Morris J. Incidence and Risk Factors of Long-term Opioid Use
in Elderly Trauma Patients. Annals of surgery 2018; 268: 985-91.
24. Hamina A, Taipale H, Tanskanen A, Tolppanen AM, Karttunen N,
Pylkkanen L, Tiihonen J, Hartikainen S. Long-term use of opioids for
nonmalignant pain among community-dwelling persons with and without
Alzheimer disease in Finland: a nationwide register-based study. Pain
2017; 158: 252-60.
25. Kuo YF, Raji MA, Chen NW, Hasan H, Goodwin JS. Trends in Opioid
Prescriptions Among Part D Medicare Recipients From 2007 to 2012.
American Journal of Medicine 2016; 129: 221.e21-21.e30.
26. McDermott JD, Eguchi M, Stokes WA, Amini A, Hararah M, Ding D,
Valentine A, Bradley CJ, Karam SD. Short- and Long-term Opioid Use in
Patients with Oral and Oropharynx Cancer. Otolaryngology - Head and Neck
Surgery (United States) 2019; 160: 409-19.
27. Salz T, Lavery JA, Lipitz-Snyderman AN, Boudreau DM, Moryl N,
Gillespie EF, Korenstein D. Trends in opioid use among older survivors
of colorectal, lung, and breast cancers. Journal of Clinical Oncology
2019; 37: 1001-11.
28. Musich S, Wang SS, Slindee L, Kraemer S, Yeh CS. Characteristics
associated with transition from opioid initiation to chronic opioid use
among opioid-naive older adults. Geriatric nursing (New York, NY) 2019;
40: 190-96.
29. Wang HT, Hill AD, Gomes T, Wijeysundera DN, Pinto R, Scales DC,
Fowler R, Wunsch H. Opioid use after ICU admission among elderly chronic
opioid users in Ontario: A population-based cohort study. Critical Care
Medicine 2018; 46: 1934-42.
30. Curtis JR, Xie F, Smith C, Saag KG, Chen L, Beukelman T, Mannion M,
Yun H, Kertesz S. Changing Trends in Opioid Use Among Patients With
Rheumatoid Arthritis in the United States. Arthritis rheumatol 2017; 69:
1733-40.
31. Richardson LP, Russo JE, Katon W, McCarty CA, DeVries A, Edlund MJ,
Martin BC, Sullivan M. Mental health disorders and long-term opioid use
among adolescents and young adults with chronic pain. J Adolesc Health
2012; 50: 553-8.
32. Wren AA, Bensen R, Sceats L, Dehghan M, Yu H, Wong JJ, MacIsaac D,
Sellers ZM, Kin C, Park KT. Starting young: Trends in opioid therapy
among US adolescents and young adults with inflammatory bowel disease in
the Truven marketscan database between 2007 and 2015. Inflamm Bowel Dis
2018; 24: 2093-103.
33. Kumthekar A, Shull S, Lovejoy TI, Morasco BJ, Chang M, Barton J.
Impact of hepatitis C treatment on pain intensity, prescription opioid
use and arthritis. International Journal of Rheumatic Diseases 2019; 22:
592-98.
34. Jeffery MM, Hooten WM, Henk HJ, Bellolio MF, Hess EP, Meara E, Ross
JS, Shah ND. Trends in opioid use in commercially insured and Medicare
Advantage populations in 2007-16: Retrospective cohort study. BMJ
(Online) 2018; 362: k2833.
35. Miceli L, Bednarova R, M DIC, Santori E, Spizzichino M, L DIM, Botti
R, Casciello M, Della Rocca G. Outpatient therapeutic chronic opioid
consumption in Italy: a one-year survey. Minerva anestesiologica 2017;
83: 33-40.
36. Nordbo A, Skurtveit S, Borchgrevink PC, Kaasa S, Fredheim OM.
Low-dose transdermal buprenorphine - long-term use and co-medication
with other potentially addictive drugs. Acta Anaesthesiol Scand 2012;
56: 88-94.
37. Carey EP, Nolan C, Kerns RD, Ho PM, Frank JW. Association Between
Facility-Level Utilization of Non-pharmacologic Chronic Pain Treatment
and Subsequent Initiation of Long-Term Opioid Therapy. Journal of
General Internal Medicine 2018; 33: 38-45.
38. Pergolizzi JV, Ben-Joseph R, Chang CL, Hess G. Predicting medication
persistence to buprenorphine transdermal system. Pain pract 2015; 15:
140-9.
39. Leider HL, Dhaliwal J, Davis EJ, Kulakodlu M, Buikema AR. Healthcare
costs and nonadherence among chronic opioid users. American Journal of
Managed Care 2011; 17: 32-40.
40. Mosher HJ, Jiang L, Vaughan Sarrazin MS, Cram P, Kaboli PJ, Vander
Weg MW. Prevalence and characteristics of hospitalized adults on chronic
opioid therapy. Journal of Hospital Medicine 2014; 9: 82-87.
41. Hoopes M, Schmidt T, Huguet N, Winters-Stone K, Angier H, Marino M,
Shannon J, DeVoe J. Identifying and characterizing cancer survivors in
the US primary care safety net. Cancer 2019.
42. Yaldo A, Wen L, Ogbonnaya A, Valderrama A, Kish J, Eaddy M, Kreilick
C, Tangirala K, Shields K. Opioid Use Among Metastatic Prostate Cancer
Patients With Skeletal-related Events. Clin Ther 2016; 38: 1880-9.
43. Barbera L, Sutradhar R, Howell D, Corn E, O’Brien MA, Seow H,
Dudgeon D, Atzema C, Earle CC, DeAngelis C, Sussman J. Factors
Associated With Opioid Use in Long-term Cancer Survivors. Journal of
Pain and Symptom Management 2019; 58: 100.
44. Boudreau DM, Chen L, Yu O, Bowles EJA, Chubak J. Risk of second
breast cancer events with chronic opioid use in breast cancer survivors.
Pharmacoepidemiology and Drug Safety 2019; 28: 740-53.
45. Edlund MJ, Austen MA, Sullivan MD, Martin BC, Williams JS, Fortney
JC, Hudson TJ. Patterns of opioid use for chronic noncancer pain in the
Veterans Health Administration from 2009 to 2011. Pain 2014; 155:
2337-43.
46. Hudson TJ, Painter JT, Gressler LE, Lu L, Silas Williams J, Booth
BM, Martin BC, Sullivan MD, Edlund MJ. Factors associated with opioid
initiation in OEF/OIF/OND veterans with traumatic brain injury. Pain
Medicine (United States) 2018; 19: 774-87.
47. Hudson TJ, Painter JT, Martin BC, Austen MA, Williams JS, Fortney
JC, Sullivan MD, Edlund MJ. Pharmacoepidemiologic analyses of opioid use
among OEF/OIF/OND veterans. Pain 2017; 158: 1039-45.
48. Edlund MJ, Martin BC, Devries A, Fan MY, Braden JB, Sullivan MD.
Trends in use of opioids for chronic noncancer pain among individuals
with mental health and substance use disorders: the TROUP study.
Clinical Journal of Pain 2010; 26: 1-8.
49. Von Korff M, Saunders K, Thomas Ray G, Boudreau D, Campbell C,
Merrill J, Sullivan MD, Rutter CM, Silverberg MJ, Banta-Green C, Weisner
C. De Facto long-term opioid therapy for noncancer pain. Clinical
Journal of Pain 2008; 24: 521-27.
50. Barnett ML, Olenski AR, Jena AB. Opioid-Prescribing Patterns of
Emergency Physicians and Risk of Long-Term Use. N Engl J Med 2017; 376:
663-73.
51. Cicero TJ, Wong G, Tian Y, Lynskey M, Todorov A, Isenberg K.
Co-morbidity and utilization of medical services by pain patients
receiving opioid medications: data from an insurance claims database.
Pain 2009; 144: 20-7.
52. Svendsen K, Skurtveit S, Romundstad P, Borchgrevink PC, Fredheim OM.
Differential patterns of opioid use: defining persistent opioid use in a
prescription database. Eur J Pain 2012; 16: 359-69.
53. Braden JB, Fan MY, Edlund MJ, Martin BC, DeVries A, Sullivan MD.
Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas
Medicaid and HealthCore enrollees: results from the TROUP study. The
journal of pain : official journal of the American Pain Society 2008; 9:
1026-35.
54. Goodwin JS, Kuo YF, Brown D, Juurlink D, Raji M. Association of
Chronic Opioid Use With Presidential Voting Patterns in US Counties in
2016. JAMA network open 2018; 1: e180450.
55. Hand BN, Krause JS, Simpson KN. Dose and Duration of Opioid Use in
Propensity Score-Matched, Privately Insured Opioid Users With and
Without Spinal Cord Injury. Archives of physical medicine and
rehabilitation 2018; 99: 855-61.
56. Hoffman EM, Watson JC, St Sauver J, Staff NP, Klein CJ. Association
of Long-term Opioid Therapy With Functional Status, Adverse Outcomes,
and Mortality Among Patients With Polyneuropathy. JAMA Neurol 2017; 74:
773-79.
57. Thielke SM, Simoni-Wastila L, Edlund MJ, DeVries A, Martin BC,
Braden JB, Fan MY, Sullivan MD. Age and sex trends in long-term opioid
use in two large American health systems between 2000 and 2005. Pain Med
2010; 11: 248-56.
58. Banerjee G, Edelman EJ, Barry DT, Crystal S, Gordon KS, Gordon AJ,
Gaither JR, Green TC, Kerns RD, Manhapra A, Moore BA, Fiellin DA,
Marshall BDL. High-dose prescribed opioids are associated with increased
risk of heroin use among United States military veterans. Pain 2019;
160: 2126-35.
59. DeVeaugh-Geiss A, Kadakia A, Chilcoat H, Alexander L, Coplan P. A
retrospective cohort study of long-term immediate-release
hydrocodone/acetaminophen use and acetaminophen dosing above the Food
and Drug Administration recommended maximum daily limit among
commercially insured individuals in the United States (2008-2013).
Journal of Pain 2015; 16: 569-79.e1.
60. Dobscha SK, Morasco BJ, Duckart JP, Macey T, Deyo RA. Correlates of
prescription opioid initiation and long-term opioid use in veterans with
persistent pain. Clinical Journal of Pain 2013; 29: 102-8.
61. Edelman EJ, Gordon KS, Becker W, Goulet JL, Skanderson M, Gaither
JR, Braden JB, Gordon A, Kerns R, Justice AC, Fiellin DA. HIV status is
an independent predictor of receiving opioid analgesics. Journal of
General Internal Medicine 2012; 2): S203-S04.
62. Gellad WF, Thorpe JM, Zhao X, Thorpe CT, Sileanu FE, Cashy JP, Hale
JA, Mor MK, Radomski TR, Hausmann LRM, Donohue JM, Gordon AJ, Suda KJ,
Stroupe KT, Hanlon JT, Cunningham FE, Good CB, Fine MJ. Impact of Dual
Use of Department of Veterans Affairs and Medicare Part D Drug Benefits
on Potentially Unsafe Opioid Use. American journal of public health
2018; 108: 248-55.
63. Hadlandsmyth K, Mosher H, Vander Weg MW, Lund BC. Decline in
Prescription Opioids Attributable to Decreases in Long-Term Use: A
Retrospective Study in the Veterans Health Administration 2010-2016.
Journal of General Internal Medicine 2018; 33: 818-24.
64. Lund BC, Ohl ME, Hadlandsmyth K, Mosher HJ. Regional and Rural-Urban
Variation in Opioid Prescribing in the Veterans Health Administration.
Military medicine 2019.
65. Merlin JS, Long D, Becker WC, Cachay ER, Christopolous KA, Claborn
KR, Crane HM, Edelman EJ, Lovejoy TI, Mathews WC, Morasco BJ, Napravnik
S, O’Cleirigh C, Saag MS, Starrels JL, Gross R, Liebschutz JM. Marijuana
Use Is Not Associated With Changes in Opioid Prescriptions or Pain
Severity Among People Living With HIV and Chronic Pain. Journal of
acquired immune deficiency syndromes (1999) 2019; 81: 231-37.
66. Steckler TJ, Mosher HJ, Desloover-Koch Y, Lund BC. Impact of
hydrocodone reclassification on analgesic prescribing in the Veterans
Health Administration. American Journal of Health-System Pharmacy 2019;
76: S61-S67.
67. Chen SK, Feldman CH, Brill G, Lee YC, Desai RJ, Kim SC. Use of
prescription opioids among patients with rheumatic diseases compared to
patients with hypertension in the USA: A retrospective cohort study. BMJ
Open 2019; 9: e027495.
68. Fulton-Kehoe D, Garg RK, Turner JA, Bauer AM, Sullivan MD, Wickizer
TM, Franklin GM. Opioid poisonings and opioid adverse effects in workers
in Washington state. Am J Ind Med 2013; 56: 1452-62.
69. Fulton-Kehoe D, Sullivan MD, Turner JA, Garg RK, Bauer AM, Wickizer
TM, Franklin GM. Opioid poisonings in Washington State Medicaid: trends,
dosing, and guidelines. Med Care 2015; 53: 679-85.
70. Sloan VS, Sheahan A, Stark JL, Suruki RY. Opioid Use in Patients
with Ankylosing Spondylitis Is Common in the United States: Outcomes of
a Retrospective Cohort Study. The Journal of rheumatology 2019.
71. Merlin JS, Tamhane A, Starrels JL, Kertesz S, Saag M, Cropsey K.
Factors Associated with Prescription of Opioids and Co-prescription of
Sedating Medications in Individuals with HIV. AIDS and behavior 2016;
20: 687-98.
72. Macey TA, Morasco BJ, Duckart JP, Dobscha SK. Patterns and
correlates of prescription opioid use in OEF/OIF veterans with chronic
noncancer pain. Pain Med 2011; 12: 1502-9.
73. Weimer MB, Macey TA, Nicolaidis C, Dobscha SK, Duckart JP, Morasco
BJ. Sex differences in the medical care of VA patients with chronic
non-cancer pain. Pain Medicine (United States) 2013; 14: 1839-47.
74. Weisberg DF, Gordon KS, Barry DT, Becker WC, Crystal S, Edelman EJ,
Gaither J, Gordon AJ, Goulet J, Kerns RD, Moore BA, Tate J, Justice AC,
Fiellin DA. Long-term Prescription of Opioids and/or Benzodiazepines and
Mortality Among HIV-Infected and Uninfected Patients. Journal of
acquired immune deficiency syndromes (1999) 2015; 69: 223-33.
75. Canan C, Alexander GC, Moore R, Murimi I, Chander G, Lau B. Medicaid
trends in prescription opioid and non-opioid use by HIV status. Drug and
Alcohol Dependence 2019; 197: 141-48.
76. Lovejoy TI, Dobscha SK, Turk DC, Weimer MB, Morasco BJ. Correlates
of prescription opioid therapy in Veterans with chronic pain and history
of substance use disorder. J Rehabil Res Dev 2016; 53: 25-36.
77. Callaghan BC, Reynolds E, Banerjee M, Kerber KA, Skolarus LE, Burke
JF. Longitudinal pattern of pain medication utilization in peripheral
neuropathy patients. Pain 2019; 160: 592-99.
78. Pauly NJ, Michailidis L, Kindred MG, Flomenhoft D, Lofwall MR, Walsh
SL, Talbert JC, Barrett TA. Predictors of Chronic Opioid Use in Newly
Diagnosed Crohn’s Disease. Inflamm Bowel Dis 2017; 23: 1004-10.
79. Quinn PD, Hur K, Chang Z, Krebs EE, Bair MJ, Scott EL, Rickert ME,
Gibbons RD, Kroenke K, D’Onofrio BM. Incident and long-term opioid
therapy among patients with psychiatric conditions and medications: a
national study of commercial health care claims. Pain 2017; 158: 140-48.
80. Shah A, Hayes CJ, Lakkad M, Martin BC. Impact of Medical Marijuana
Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid
Use. Journal of General Internal Medicine 2019.
81. Thornton JD, Dwibedi N, Scott V, Ponte CD, Ziedonis D, Sambamoorthi
N, Sambamoorthi U. Predictors of transitioning to incident chronic
opioid therapy among working-age adults in the United States. American
Health and Drug Benefits 2018; 11: 12-21.
82. Bertenthal D, Yaffe K, Barnes DE, Byers AL, Gibson CJ, Seal KH,
Chronic Effects of Neurotrauma Consortium Study G. Do postconcussive
symptoms from traumatic brain injury in combat veterans predict risk for
receiving opioid therapy for chronic pain? Brain injury 2018; 32:
1188-96.
83. Seal KH, Bertenthal D, Barnes DE, Byers AL, Gibson CJ, Rife TL,
Yaffe K. Traumatic Brain Injury and Receipt of Prescription Opioid
Therapy for Chronic Pain in Iraq and Afghanistan Veterans: Do Clinical
Practice Guidelines Matter? Journal of Pain 2018.
84. Braden JB, Sullivan MD, Ray GT, Saunders K, Merrill J, Silverberg
MJ, Rutter CM, Weisner C, Banta-Green C, Campbell C, Von Korff M. Trends
in long-term opioid therapy for noncancer pain among persons with a
history of depression. Gen Hosp Psychiatry 2009; 31: 564-70.
85. Calcaterra SL, Yamashita TE, Min SJ, Keniston A, Frank JW,
Binswanger IA. Opioid Prescribing at Hospital Discharge Contributes to
Chronic Opioid Use. Journal of General Internal Medicine 2016; 31:
478-85.
86. Campbell CI, Weisner C, Leresche L, Ray GT, Saunders K, Sullivan MD,
Banta-Green CJ, Merrill JO, Silverberg MJ, Boudreau D, Satre DD, Von
Korff M. Age and gender trends in long-term opioid analgesic use for
noncancer pain. Am J Public Health 2010; 100: 2541-7.
87. Hooten WM, Lamer TJ, Twyner C. Opioid-induced hyperalgesia in
community-dwelling adults with chronic pain. Pain 2015; 156: 1145-52.
88. Jeffery MM, Hooten WM, Hess EP, Meara ER, Ross JS, Henk HJ,
Borgundvaag B, Shah ND, Bellolio MF. Opioid Prescribing for Opioid-Naive
Patients in Emergency Departments and Other Settings: Characteristics of
Prescriptions and Association With Long-Term Use. Annals of Emergency
Medicine 2018; 71: 326-36.e19.
89. Ray GT, Bahorik AL, VanVeldhuisen PC, Weisner CM, Rubinstein AL,
Campbell CI. Prescription opioid registry protocol in an integrated
health system. American Journal of Managed Care 2017; 23: e146-e55.
90. Silverberg MJ, Ray GT, Saunders K, Rutter CM, Campbell CI, Merrill
JO, Sullivan MD, Banta-Green CJ, Von Korff M, Weisner C. Prescription
long-term opioid use in HIV-infected patients. Clinical Journal of Pain
2012; 28: 39-46.
91. Weisner CM, Campbell CI, Ray GT, Saunders K, Merrill JO, Banta-Green
C, Sullivan MD, Silverberg MJ, Mertens JR, Boudreau D, Von Korff M.
Trends in prescribed opioid therapy for non-cancer pain for individuals
with prior substance use disorders. Pain 2009; 145: 287-93.
92. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD,
Campbell CI, Merrill JO, Silverberg MJ, Banta-Green C, Weisner C. Trends
in long-term opioid therapy for chronic non-cancer pain.
Pharmacoepidemiol Drug Saf 2009; 18: 1166-75.
93. Fritz JM, King JB, McAdams-Marx C. Associations between Early Care
Decisions and the Risk for Long-term Opioid Use for Patients with Low
Back Pain with a New Physician Consultation and Initiation of Opioid
Therapy. Clinical Journal of Pain 2018; 34: 552-58.
94. Lavin RA, Kalia N, Yuspeh L, Barry JA, Bernacki EJ, Tao XG. Work
Enabling Opioid Management. Journal of Occupational and Environmental
Medicine 2017; 59: 761-64.
95. Richardson E, Bedson J, Chen Y, Lacey R, Dunn KM. Increased risk of
reproductive dysfunction in women prescribed long-term opioids for
musculoskeletal pain: A matched cohort study in the Clinical Practice
Research Datalink. European Journal of Pain (United Kingdom) 2018; 22:
1701-08.
96. Calcaterra SL, Scarbro S, Hull ML, Forber AD, Binswanger IA, Colborn
KL. Prediction of Future Chronic Opioid Use Among Hospitalized Patients.
Journal of General Internal Medicine 2018; 33: 898-905.
97. Rogers KD, Kemp A, McLachlan AJ, Blyth F. Adverse selection? A
multi-dimensional profile of people dispensed opioid analgesics for
persistent non-cancer pain. PLoS ONE 2013; 8: e80095.
98. Bedson J, Chen Y, Hayward RA, Ashworth J, Walters K, Dunn KM, Jordan
KP. Trends in long-term opioid prescribing in primary care patients with
musculoskeletal conditions: An observational database study. Pain 2016;
157: 1525-31.
99. Mosher HJ, Richardson KK, Lund BC. The 1-year treatment course of
new opioid recipients in veterans health administration. Pain Medicine
(United States) 2016; 17: 1282-91.
100. Deyo RA, Smith DH, Johnson ES, Donovan M, Tillotson CJ, Yang X,
Petrik AF, Dobscha SK. Opioids for back pain patients: primary care
prescribing patterns and use of services. J Am Board Fam Med 2011; 24:
717-27.
101. Deyo RA, Smith DH, Johnson ES, Tillotson CJ, Donovan M, Yang X,
Petrik A, Morasco BJ, Dobscha SK. Prescription opioids for back pain and
use of medications for erectile dysfunction. Spine 2013; 38: 909-15.
102. Smolina K, Gladstone EJ, Rutherford K, Morgan SG. Patterns and
trends in long-term opioid use for non-cancer pain in British Columbia,
2005-2012. Can J Public Health 2016; 107: e404-e09.
103. Barnett ML, Zhao X, Fine MJ, Thorpe CT, Sileanu FE, Cashy JP, Mor
MK, Radomski TR, Hausmann LRM, Good CB, Gellad WF. Emergency Physician
Opioid Prescribing and Risk of Long-term Use in the Veterans Health
Administration: an Observational Analysis. Journal of General Internal
Medicine 2019.
104. Painter JT, Crofford LJ, Butler JS, Talbert J. Healthcare costs
associated with chronic opioid use and fibromayalgia syndrome. American
Journal of Pharmacy Benefits 2014; 6: e177-e84.
105. Shah A, Hayes CJ, Martin BC. Factors Influencing Long-Term Opioid
Use Among Opioid Naive Patients: An Examination of Initial Prescription
Characteristics and Pain Etiologies. Journal of Pain 2017; 18: 1374-83.
106. Shah A, Hayes CJ, Martin BC. Characteristics of Initial
Prescription Episodes and Likelihood of Long-Term Opioid Use - United
States, 2006-2015. MMWR Morb Mortal Wkly Rep 2017; 66: 265-69.
107. Upadhye S. Creating opioid dependence in the emergency department.
CJEM 2018; 20: 100-03.
108. Kern DM, Zhou S, Chavoshi S, Tunceli O, Sostek M, Singer J,
LoCasale RJ. Treatment patterns, healthcare utilization, and costs of
chronic opioid treatment for non-cancer pain in the United States.
American Journal of Managed Care 2015; 21: e222-34.
109. Chevalier P, Smulders M, Chavoshi S, Sostek M, LoCasale R. A
description of clinical characteristics and treatment patterns observed
within prescribed opioid users in Germany and the UK. Pain manag 2014;
4: 267-76.
110. Kern DM, Chang L, Sonawane K, Larmore CJ, Boytsov NN, Quimbo RA,
Singer J, Hinton JT, Wu SJ, Araujo AB. Treatment Patterns of Newly
Diagnosed Rheumatoid Arthritis Patients from a Commercially Insured
Population. Rheumatology and Therapy 2018; 5: 355-69.
111. Birke H, Ekholm O, Sjogren P, Kurita GP, Hojsted J. Long-term
opioid therapy in Denmark: A disappointing journey. European Journal of
Pain (United Kingdom) 2017; 21: 1516-27.
112. Ekholm O, Kurita GP, Hojsted J, Juel K, Sjogren P. Chronic pain,
opioid prescriptions, and mortality in Denmark: A population-based
cohort study. Pain 2014; 155: 2486-90.
113. Hojsted J, Ekholm O, Kurita GP, Juel K, Sjogren P. Addictive
behaviors related to opioid use for chronic pain: A population-based
study. Pain 2013; 154: 2677-83.
114. Northrup TF, Carroll K, Suchting R, Villarreal YR, Zare M, Stotts
AL. The Impact of Increased Hydrocodone Regulation on Opioid Prescribing
in an Urban Safety-Net Health Care System. Journal of the American Board
of Family Medicine : JABFM 2019; 32: 362-74.
115. Lentz TA, Rhon DI, George SZ. Predicting Opioid Use, Increased
Health Care Utilization and High Costs for Musculoskeletal Pain: What
Factors Mediate Pain Intensity and Disability? Journal of Pain 2019.
116. Cichowski SB, Rogers RG, Komesu Y, Murata E, Qualls C, Murata A,
Murata G. A 10-yr Analysis of Chronic Pelvic Pain and Chronic Opioid
Therapy in the Women Veteran Population. Military medicine 2018; 183:
e635-e40.
117. Heins SE, Feldman DR, Bodycombe D, Wegener ST, Castillo RC. Early
opioid prescription and risk of long-term opioid use among US workers
with back and shoulder injuries: a retrospective cohort study. Inj Prev
2016; 22: 211-5.
118. Chen JH, Hom J, Richman I, Asch SM, Podchiyska T, Johansen NA.
Effect of opioid prescribing guidelines in primary care. Medicine
(United States) 2016; 95 (35) (no pagination).
119. Lee SS, Choi Y, Pransky GS. Extent and Impact of Opioid Prescribing
for Acute Occupational Low Back Pain in the Emergency Department. J
Emerg Med 2016; 50: 376-84.e1-2.
120. Rose AJ, Hermos JA, Frayne SM, Pogach LM, Berlowitz DR, Miller DR.
Does opioid therapy affect quality of care for diabetes mellitus?
American Journal of Managed Care 2009; 15: 217-24.
121. Azad TD, Vail D, Bentley J, Han SS, Suarez P, Varshneya K, Mittal
V, Veeravagu A, Desai M, Bhattacharya J, Ratliff JK. Initial Provider
Specialty Is Associated With Long-term Opiate Use in Patients With Newly
Diagnosed Low Back and Lower Extremity Pain. Spine 2019; 44: 211-18.
122. Deyo RA, Hallvik SE, Hildebran C, Marino M, Dexter E, Irvine JM,
O’Kane N, Van Otterloo J, Wright DA, Leichtling G, Millet LM.
Association Between Initial Opioid Prescribing Patterns and Subsequent
Long-Term Use Among Opioid-Naive Patients: A Statewide Retrospective
Cohort Study. Journal of General Internal Medicine 2017; 32: 21-27.
123. Hadlandsmyth K, Lund BC, Mosher HJ. Associations between initial
opioid exposure and the likelihood for long-term use. Journal of the
American Pharmacists Association 2019; 59: 17-22.
124. Morden NE, Munson JC, Colla CH, Skinner JS, Bynum JP, Zhou W, Meara
E. Prescription opioid use among disabled Medicare beneficiaries:
intensity, trends, and regional variation. Med Care 2014; 52: 852-9.
125. Svendsen K, Fredheim OM, Romundstad P, Borchgrevink PC, Skurtveit
S. Persistent opioid use and socio-economic factors: a population-based
study in Norway. Acta Anaesthesiol Scand 2014; 58: 437-45.
126. Fredheim OM, Mahic M, Skurtveit S, Dale O, Romundstad P,
Borchgrevink PC. Chronic pain and use of opioids: a population-based
pharmacoepidemiological study from the Norwegian prescription database
and the Nord-Trondelag health study. Pain 2014; 155: 1213-21.
127. Mellbye A, Karlstad O, Skurtveit S, Borchgrevink PC, Fredheim OM.
The duration and course of opioid therapy in patients with chronic
non-malignant pain. Acta Anaesthesiol Scand 2016; 60: 128-37.
128. Meisel ZF, Lupulescu-Mann N, Charlesworth CJ, Kim H, Sun BC.
Conversion to Persistent or High-Risk Opioid Use After a New
Prescription From the Emergency Department: Evidence From Washington
Medicaid Beneficiaries. Annals of Emergency Medicine 2019.
129. Skurtveit S, Furu K, Borchgrevink P, Handal M, Fredheim O. To what
extent does a cohort of new users of weak opioids develop persistent or
probable problematic opioid use? Pain 2011; 152: 1555-61.
130. Chang HY, Murimi I, Faul M, Rutkow L, Alexander GC. Impact of
Florida’s prescription drug monitoring program and pill mill law on
high-risk patients: A comparative interrupted time series analysis.
Pharmacoepidemiology and Drug Safety 2018; 27: 422-29.
131. Chaudhary MA, Scully R, Jiang W, Chowdhury R, Zogg CK, Sharma M,
Ranjit A, Koehlmoos T, Haider AH, Schoenfeld AJ. Patterns of use and
factors associated with early discontinuation of opioids following major
trauma. American journal of surgery 2017; 214: 792-97.
132. Kwok AK, O’Hara NN, Pollak AN, O’Hara LM, Herman A, Welsh CJ,
Slobogean GP. Are injured workers with higher rehabilitation service
utilization less likely to be persistent opioid users? A cross-sectional
study. BMC health services research 2019; 19: 32.
133. Zamora-Legoff JA, Achenbach SJ, Crowson CS, Krause ML, Davis JM,
3rd, Matteson EL. Opioid use in patients with rheumatoid arthritis
2005-2014: a population-based comparative study. Clin Rheumatol 2016;
35: 1137-44.
134. Riva JJ, Noor ST, Wang L, Ashoorion V, Foroutan F, Sadeghirad B,
Couban R, Busse JW. Predictors of Prolonged Opioid Use After Initial
Prescription for Acute Musculoskeletal Injuries in Adults: A Systematic
Review and Meta-analysis of Observational Studies. Annals of internal
medicine 2020.
135. Edlund MJ, Martin BC, Russo JE, DeVries A, Braden JB, Sullivan MD.
The role of opioid prescription in incident opioid abuse and dependence
among individuals with chronic noncancer pain: the role of opioid
prescription. The Clinical journal of pain 2014; 30: 557-64.